Differential response to PCSK-9 inhibitor therapy is related to the type of low density lipoprotein receptor gene mutation in patients with homozygous familial hypercholesterolaemia. (December 2020)

Record Type:
Journal Article
Title:
Differential response to PCSK-9 inhibitor therapy is related to the type of low density lipoprotein receptor gene mutation in patients with homozygous familial hypercholesterolaemia. (December 2020)
Main Title:
Differential response to PCSK-9 inhibitor therapy is related to the type of low density lipoprotein receptor gene mutation in patients with homozygous familial hypercholesterolaemia
Authors:
Mohd Kasim, N.A.
Nazli, S.A.
Muhmad Hamidi, M.H.
Chua, Y.A.
Sani, H.
Kasim, S.S.
Mohd Nawawi, H.
Abstract:
Is Part Of:
Atherosclerosis. Volume 315(2020)
Journal:
Atherosclerosis
Issue:
Volume 315(2020)
Issue Display:
Volume 315, Issue 2020 (2020)
Year:
2020
Volume:
315
Issue:
2020
Issue Sort Value:
2020-0315-2020-0000
Page Start:
e42
Page End:
Publication Date:
2020-12
Subjects:
Arteriosclerosis -- Periodicals
Electronic journals
616.136
Journal URLs:
http://www.sciencedirect.com/science/journal/00219150 ↗
http://www.clinicalkey.com/dura/browse/journalIssue/00219150 ↗
http://www.elsevier.com/journals ↗
DOI:
10.1016/j.atherosclerosis.2020.10.135 ↗
Languages:
English
ISSNs:
0021-9150
Deposit Type:
Legaldeposit
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗
Physical Locations:
British Library DSC - 1765.874000
British Library DSC - BLDSS-3PM
British Library HMNTS - ELD Digital store
Ingest File:
16063.xml